About
Olmesartan is an angiotensin II receptor blocker (ARB) primarily used in the management of hypertension. It works by selectively blocking the binding of angiotensin II to the AT1 receptor in various tissues, including vascular smooth muscle and the adrenal gland. This blockade prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to a reduction in blood pressure. Its mechanism of action results in vasodilation, decreased peripheral vascular resistance, and reduced sodium and water retention, contributing to its antihypertensive efficacy.
The drug is well-absorbed orally and typically administered once daily, offering sustained blood pressure control. It is particularly beneficial for patients who cannot tolerate ACE inhibitors due to cough. Regular monitoring of blood pressure and renal function is recommended during treatment to ensure optimal therapeutic outcomes and manage potential adverse effects.
Uses
- Treatment of essential hypertension.
- Reduction of cardiovascular risk in high-risk patients.
- Management of diabetic nephropathy (off-label for some ARBs, but common for class).
- Prevention of stroke and myocardial infarction in hypertensive patients.
Directions For Use
Take orally once daily, with or without food, as directed by your physician. Do not crush or chew the tablet.
Benefits
- Effective blood pressure reduction.
- Low incidence of cough compared to ACE inhibitors.
- Provides sustained 24-hour blood pressure control.
- Reduces risk of cardiovascular events.
- May protect kidney function in hypertensive diabetics.
- Generally well-tolerated by most patients.
Side Effects
- Dizziness
- Headache
- Fatigue
- Nausea
- Diarrhea
- Back pain
- Upper respiratory tract infection
- Hyperkalemia
- Hypotension
- Renal dysfunction
- Angioedema (rare)
- Muscle cramps
Safety Measures
- Alcohol - Concurrent use of alcohol may enhance the hypotensive effect of Olmesartan, leading to increased dizziness or lightheadedness. It is advisable to limit alcohol intake.
- Pregnancy - Olmesartan is contraindicated in pregnancy, especially during the second and third trimesters, due to the risk of fetal injury or death.
- Breastfeeding - It is not known if Olmesartan is excreted in human milk. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
- Liver - Use with caution in patients with severe hepatic impairment, as dosage adjustments may be necessary.
- Kidney - Use with caution in patients with renal impairment; regular monitoring of kidney function and serum potassium is essential.
- Lung - Generally safe for use in patients with lung conditions, as it does not typically cause respiratory side effects like cough associated with ACE inhibitors.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!